CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 86 filers reported holding CHEMOCENTRYX INC in Q4 2017. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $27,000 | -37.2% | 3,920 | -15.4% | 0.00% | – |
Q2 2019 | $43,000 | -32.8% | 4,632 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $64,000 | +10.3% | 4,632 | -13.4% | 0.00% | 0.0% |
Q4 2018 | $58,000 | -39.6% | 5,350 | -29.7% | 0.00% | 0.0% |
Q3 2018 | $96,000 | +88.2% | 7,614 | +100.4% | 0.00% | 0.0% |
Q2 2018 | $51,000 | +15.9% | 3,800 | +18.8% | 0.00% | 0.0% |
Q1 2018 | $44,000 | +144.4% | 3,200 | +6.7% | 0.00% | – |
Q4 2017 | $18,000 | +28.6% | 3,000 | +100.0% | 0.00% | – |
Q2 2017 | $14,000 | – | 1,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,796,516 | $45,142,000 | 7.90% |
GREAT POINT PARTNERS LLC | 1,000,000 | $5,790,000 | 4.09% |
Belmont Global Advisors, Inc. | 175,000 | $1,013,000 | 0.82% |
Broadfin Capital, LLC | 1,033,668 | $5,985,000 | 0.79% |
WASATCH ADVISORS LP | 2,650,551 | $15,347,000 | 0.15% |
BALYASNY ASSET MANAGEMENT L.P. | 1,158,613 | $6,708,000 | 0.09% |
Artal Group S.A. | 275,000 | $1,592,000 | 0.06% |
STONERIDGE INVESTMENT PARTNERS LLC | 41,355 | $239,000 | 0.05% |
A.R.T. Advisors, LLC | 33,501 | $193,000 | 0.01% |
BANQUE PICTET & CIE SA | 50,932 | $295,000 | 0.01% |